Get notified of page updates

BRIP1: Screening & Prevention

Learn about the screening and prevention guidelines for people with a mutation in their BRIP1 gene. Stay up to date by signing up for our community newsletter.
Glossary on
off

Risk Management for People with Inherited BRIP1 Mutations

People with  mutations have options for managing their increased cancer risk. Experts at the National Comprehensive Cancer Network (NCCN) created guidelines for people with a mutation to manage their cancer risk.

We recommend that you speak with a genetics expert who can look at your personal and family history of cancer and can help you decide on a plan to manage your risk. You can learn more about risk management options in our section on screening and risk reduction by cancer type. 

Ovarian and cancer risk management

Beginning Age

Recommendation

Additional Information

45-50
(or earlier based on the youngest case of ovarian cancer in the family)

Surgical removal of ovaries and

Risk-reducing removal of ovaries and ().

  • Discuss your plans for pregnancy and fertility concerns with your doctor, and request a referral to a fertility specialist if indicated.
  • Discuss options for managing the effects of early menopause with your doctor.
  • After , a very small risk remains for a related cancer known as primary peritoneal cancer (PPC). There is no effective screening for PPC after .

At the time of surgical removal of the ovaries

Surgical removal of the uterus

mutations are not known to increase the risk of . However, some people may choose to have their uterus removed at the time as risk-reducing surgery to remove the ovaries and .

Talk with your healthcare team about the possible benefits, risks and costs of hysterectomy as part of your surgical plan.

The following factors may affect your decision about hysterectomy at the time of RRSO:

  • If you have a medical history of fibroids or other issues involving the uterus or cervix you might consider a hysterectomy.
  • If you are considering hormone replacement, the type of hormone recommended depends on whether or not you have your uterus.
    • alone increases the risk for uterine cancer.
    • combined with progesterone protects against uterine cancer, but is linked to a higher risk for breast cancer than alone.

Before age 50

(removal of the only)

Researchers are studying whether the removal of the only (), while delaying until closer to the age of natural menopause is a safe option for lowering risk in people who are not ready to remove their ovaries. If you are interested in this approach, talk with your doctor about the benefits and risks, and consider enrolling in a research study.

  • , followed by delayed requires two separate surgeries.
  • At this time, it is not known how effective is for lowering the ovarian cancer risk in high-risk people.

For women who choose this surgery, the guidelines also recommend the following:

  • If you choose to have risk-reducing first, the guidelines recommend that you undergo surgery to remove your ovaries (known as a completion ) at the recommended age.
  • Discuss your plans for pregnancy and fertility concerns with your doctor, and request a referral to a fertility specialist prior to surgery.
  • The surgery should include a procedure known as an abdominal wash at the time of surgery. The pathologist should do an extensive exam of the using a procedure called SEE-FIM to look for any abnormal changes in the tissue.
  • If an abnormality known as a "serous tubal intraepithelial carcinoma" or STIC lesion is noted in your , you should be referred to a gynecologic oncologist for follow up care.

No set age

Medications to lower your risk

Oral contraceptives (birth control pills) have been shown to lower the risk for ovarian cancer in people with increased risk. Have a discussion with your doctor about the benefits and risks of oral contraceptives for lowering ovarian cancer risk.

Research on the effect of oral contraceptives on breast cancer risk has been mixed.

No set age

Symptom awareness

Become aware of ovarian and primary peritoneal cancer symptoms. Report any symptoms that persist for several weeks and are a change from normal to your doctor.

Routine ovarian cancer screening using transvaginal and a blood test has not shown benefit and is not recommended.

Symptoms of ovarian cancer include:

  • pelvic or abdominal pain
  • bloating or distended belly
  • difficulty eating
  • feeling full sooner than normal
  • increased urination or pressure to urinate

Source: NCCN Guidelines: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and , v. 1, 2027.

Other cancers

There isn’t enough research to show that people with a mutation benefit from extra screening or prevention for other types of cancer. Because of this, experts recommend following general population screening guidelines and considering your family history when managing these risks. National guidelines exist for screening the following cancers:

Participate in Prevention Research

Below are some of our featured research studies looking at new ways to screen for, prevent or intercept cancer in people with mutations. To search for additional studies, visit our Search and Enroll Tool. 

More Resources

Find Compassionate Support

Making treatment decisions may feel overwhelming or isolating. You don't have to face this alone. Find support from people who have been there and understand. 

 

Learn More

Get Help Locating Resources

Connect with a trained volunteer who can help you navigate the decisions you face about hereditary cancer or cancer risk. 

 

Learn More

Learn More About Hereditary Cancers

Visit our section with in-depth information on screening, prevention or treatment of different types of cancer.

 

 

Learn More

Last updated September 21, 2026